72 filings
Page 3 of 4
DEF 14A
x7y qfbiyawvjzmgqn
2 May 22
Definitive proxy
7:01am
10-K
8d56edp
10 Mar 22
Annual report
6:38am
8-K
ohmei6bxej
10 Mar 22
Immuneering Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
6:30am
8-K
d4li sxn1dnsr
18 Jan 22
Industry Executive Brings More than 20 Years of Clinical Drug Development Expertise
6:56am
8-K
ik900 wamc
22 Dec 21
Entry into a Material Definitive Agreement
6:04am
8-K
6j3aranr
9 Nov 21
Immuneering Reports Third Quarter 2021 Financial Results and Recent Business Highlights
6:30am
10-Q
eaxaxpmtkmh7
9 Sep 21
Quarterly report
6:41am
8-K
3mkk rpjtwbjawt
9 Sep 21
Immuneering Reports Second Quarter 2021 Financial Results and Provides Business Updates
6:30am
S-8
39qk f2jyyb
3 Aug 21
Registration of securities for employees
4:47pm
424B4
ajafwe
30 Jul 21
Prospectus supplement with pricing info
4:13pm
EFFECT
feckcznk3 2m2kedyt
30 Jul 21
Notice of effectiveness
12:16am
S-1MEF
xa23kp09o
29 Jul 21
Registration of additional securities for an S-1
8:34pm
CORRESP
zn82176ayt
28 Jul 21
Correspondence with SEC
12:00am
CERT
o7jp6sex
27 Jul 21
Certification of approval for exchange listing
4:58pm
8-A12B
4yw8dvbgc mshyto
27 Jul 21
Registration of securities on exchange
12:00am
UPLOAD
noo8 3uuy
27 Jul 21
Letter from SEC
12:00am
CORRESP
7iupf1gizvnvirn51t
27 Jul 21
Correspondence with SEC
12:00am
CORRESP
qm5avt 1bax
27 Jul 21
Correspondence with SEC
12:00am